Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?

International Journal of Tuberculosis and Lung Disease

Volumn 2, Issue 1, 1998, Pages 52-55

  Wilkinson, David ^a,b,c   Bechan, S ^a   Connolly, C ^a   Standing, E ^d   Short, G M ^e  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c Hlabisa Hospital   (South Africa)

^d Pinetown Municipality ^*

^e Regional Office   (South Africa)

Author keywords

Sputum smear examination; Treatment history; Tuberculosis

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; ANAMNESIS; ARTICLE; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; SOUTH AFRICA; SPUTUM SMEAR; TREATMENT FAILURE;

ADULT; AMBULATORY CARE; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; COHORT STUDIES; CONFIDENCE INTERVALS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; ISONIAZID; MALE; MEDICAL HISTORY TAKING; PREDICTIVE VALUE OF TESTS; PYRAZINAMIDE; RECURRENCE; RETREATMENT; RIFAMPIN; RISK FACTORS; SAFETY; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM; STREPTOMYCIN; TREATMENT FAILURE; TUBERCULOSIS, PULMONARY;

EID: 0031935245     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Harries A D, Maher D. TB/HIV. A clinical manual. WHO/TB/ 96.200. Geneva: World Health Organisation, 1996.
2. Chan S L. Chemotherapy of tuberculosis. In: Davies P. D. O. ed. Clinical tuberculosis. 1st ed. London: Chapman and Hall, 1994: 141-156.
3. De Cock K M, Wilkinson D. Tuberculosis control in resource-poor countries: alternative strategies in the era of HIV. Lancet 1995; 346: 675-677.
4. Wilkinson D. High compliance tuberculosis treatment programme in a rural community. Lancet 1994; 343: 647-648.
5. Wilkinson D, Davies G R, Connolly C. Directly observed therapy for tuberculosis in rural South Africa, 1991 through 1994. Am J Public Health 1996; 86: 1094-1097.
6. Wilkinson D, Anderson E, Davies G R, Sturm A W, McAdam K P W J. Efficacy of twice-weekly treatment for tuberculosis given under direct observation in Africa. Trans Roy Soc Trop Med Hyg 1997; 91: 87-89.
7. De Cock K M, Soro B, Coulibaly I M, Lucas S B. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992; 268; 1581-1587.
8. Ravighone M C, Snider D E, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a world-wide epidemic. JAMA 1995; 273: 220-226.
9. Gilks C F, Haran D, Wilkinson D. Coping with the impact of the HIV epidemic - the Hlabisa-Liverpool Link. S Afr Med J 1996; 86: 1077-1078.
10. Bechan S, Connolly C, Short G M, Standing E, Wilkinson D. Directly observed therapy for tuberculosis given twice weekly in the workplace in urban South Africa. Trans Roy Soc Trop Med Hyg 1997 (in press).
11. Mundy C F J, Chintolo F E, Gilks C F. The burden of sputum smear microscopy on laboratory services in Malawi. Royal Society of Tropical Medicine and Hygiene Third Residential Meeting, Christ's College, Cambridge 18-20 September 1996.
12. Squire S B, Nyasulu I K, Kanyerere H, Salaniponi F M L. Why bother with three sputum smears for case-finding in tuberculosis control? Royal Society of Tropical Medicine and Hygiene Third Residential Meeting, Christ's College, Cambridge 18-20 September 1996.
13. Mitchison D A, Nunn A J. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133: 865-866.
14. Hennekens C H, Buring J E. Epidemiology in medicine. 1st ed. Boston/Toronto: Little, Brown, 1987.
15. Rieder H L. Sputum smear conversion during directly observed treatment for tuberculosis. Tubercle Lung Dis 1996; 77: 101-196.